Citigroup’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,000
Closed -$150K 6597
2022
Q1
$150K Buy
+5,000
New +$135K ﹤0.01% 4226
2021
Q1
Sell
-120
Closed -$4K 7192
2020
Q4
$4K Sell
120
-210
-64% -$6.08K ﹤0.01% 7159
2020
Q3
$8K Buy
330
+130
+65% +$3.19K ﹤0.01% 6775
2020
Q2
$4K Sell
200
-190
-49% -$3.42K ﹤0.01% 7320
2020
Q1
$6K Sell
390
-10
-3% -$213 ﹤0.01% 7236
2019
Q4
$9K Buy
+400
New +$8.24K ﹤0.01% 7240
2019
Q1
Sell
-760
Closed -$17K 7773
2018
Q4
$17K Buy
760
+120
+19% +$3.39K ﹤0.01% 6956
2018
Q3
$21K Buy
640
+450
+237% +$13.5K ﹤0.01% 7063
2018
Q2
$5K Buy
190
+30
+19% +$1.07K ﹤0.01% 7357
2018
Q1
$6K Buy
160
+10
+7% +$400 ﹤0.01% 7172
2017
Q4
$6K Sell
150
-260
-63% -$9.89K ﹤0.01% 7195
2017
Q3
$10K Buy
410
+90
+28% +$2.19K ﹤0.01% 6698
2017
Q2
$9K Sell
320
-100
-24% -$2.74K ﹤0.01% 6573
2017
Q1
$14K Buy
420
+320
+320% +$8.15K ﹤0.01% 6428
2016
Q4
$2K Buy
+100
New +$2.86K ﹤0.01% 7066

Other funds holding RIGL